Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Glenmark Life Sciences IPO.
April 25, 2024 2:03:00 PM
Indian drugmaker Glenmark Life Sciences posted its first drop in profit for six quarters on Thursday as its mainstay active pharmaceutical ingredients (API) business was hurt by the Red Sea crisis.
Published by : ReutersApril 22, 2024 2:37:00 PM
Apr 18, 2024 17:00 Source: BSE Glenmark Life Sciences - Board Meeting Intimation for To Consider And Approve Audited Financial Results Of The Company For The Quarter And Year Ended March 31 ...
Published by : moneycontrol.comSeptember 18, 2021 3:24:00 PM
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment.
Published by : India InfolineApril 25, 2024 4:36:59 AM
Bajaj Finance, Nestle India, Tech Mahindra, IndusInd Bank, Schaeffler India, ACC, MphasiS, Coromandel International, Laurus Labs, Cyient, TTML, Olectra Greentech, etc. will announce their Q4 results t ...
Published by : Live Mint on MSNApril 25, 2024 6:09:41 AM
Bajaj Finance, Nestle India, Vedanta, Tech Mahindra, ACC, L&T Technology Services, IndusInd Bank, Glenmark Life Sciences, Laurus LabsTanla Platforms, Tata Teleservices (Maharashtra), UTI Asset ...
Published by : ET Now on MSNApril 19, 2024 3:30:00 AM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Published by : MorningstarJuly 25, 2023 2:55:00 AM
They believe the company, which is a spin off of Glenmark Pharma, is well placed in the Active Pharmaceutical Ingredient (API) business. Get updates on your preferred social platform Follow us for ...
Published by : health.economictimes.indiatimesApril 16, 2024 3:30:00 AM
Glenmark Life Sciences Ltd share price was up by 1.13% from the previous closing price of ?791.10. Who are peers of Glenmark Life Sciences Ltd? The peers of Glenmark Life Sciences Ltd are Sun ...
Published by : Business TodayApril 15, 2024 3:30:00 AM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Published by : MorningstarJanuary 20, 2024 10:42:00 PM
Stay Updated with Latest Share Market News, Share Market Live Updates, Sensex Today, Nifty Live, IPO News, BSE/NSE News, Mutual Funds and Commodity Market News Updates on Business Standard.
Published by : Business StandardThe IPO Shares of Glenmark Life Sciences Limited IPO are proposed to list on Friday, August 6, 2021 at BSE, NSE. The public issue of Glenmark Life Sciences IPO was opened on Jul 27, 2021 and closed for subscription on Jul 29, 2021. Glenmark Life Sciences IPO Listing Date and Information:
| Listing Date | Friday, August 6, 2021 |
| BSE Script Code | 543322 |
| NSE Symbol | GLS |
| Listing In | B Group of Securities |
| ISIN | INE03Q201024 |
| Issue Price | ₹720 Per Equity Share |
| Face Value | ₹2 Per Equity Share |
The allotment status of Glenmark Life Sciences Limited IPO is now available online. The public issue of Glenmark Life Sciences IPO was open on Jul 27, 2021 and closed for subscription on Jul 29, 2021. The equity shares of the company to be list at BSE, NSE
.
Glenmark Life Sciences Limited is entering in the capital market with an IPO of [.] Equity Shares of Rs 2 aggregating up to Rs [.] Crore. The price for the issue has been set at Rs - Rs Per Equity Share.
Incorporated in 2011, Glenmark Life Sciences is the leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. It further operates in Contract Development and manufacturing operations (CDMO) to offer services to specialty Pharmaceutical companies.
The issue opens on Jul 27, 2021 and closes for subscription on Jul 29, 2021. The equity shares of the company to be list at BSE, NSE.
The issue of Glenmark Life Sciences Limited opens on Jul 27, 2021 and closes for subscription on Jul 29, 2021. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs - Rs Per Equity Share.
The Glenmark Life Sciences IPO is proposed to open on July 27, 2021. The IPO application ends on July 29, 2021.
Retail investors can apply in the retail or non-institutional investor category from July 27, 2021 to July 29, 2021. The Glenmark Life Sciences IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Glenmark Life Sciences IPO will open for subscription on July 27, 2021. The public issue will close on July 29, 2021.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
